OneFund LLC’s Biogen BIIB Stock Holding History

OneFund LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.1K	Hold	403	–	–	0.05%	295
2026 Q1	$74.1K	Sell	403 -8	-2%	-$1.47K	0.05%	316
2025 Q4	$72.3K	Buy	411 +27	+7%	+$4.41K	0.04%	316
2025 Q3	$53.8K	Buy	384 +11	+3%	+$1.49K	0.03%	370
2025 Q2	$47K	Buy	+373	New	+$46.5K	0.03%	380

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OneFund LLC's BIIB Position: Q2 2026 in Review

OneFund LLC held its Biogen (BIIB) position steady in Q2 2026 at 403 shares worth $87.1K. The position accounts for 0.05% of the portfolio, ranked #295.

OneFund LLC first reported a position in BIIB in Q2 2025 and has held it in 5 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

OneFund LLC held 403 shares of Biogen worth $87.1K as of Q2 2026.
OneFund LLC left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.05% of OneFund LLC's portfolio in Q2 2026, its #295 holding.
OneFund LLC first reported a position in Biogen in Q2 2025 and has held it in 5 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.